1. Home
  2. TATT vs LXRX Comparison

TATT vs LXRX Comparison

Compare TATT & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TATT
  • LXRX
  • Stock Information
  • Founded
  • TATT 1985
  • LXRX 1995
  • Country
  • TATT Israel
  • LXRX United States
  • Employees
  • TATT N/A
  • LXRX N/A
  • Industry
  • TATT Aerospace
  • LXRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • TATT Industrials
  • LXRX Health Care
  • Exchange
  • TATT Nasdaq
  • LXRX Nasdaq
  • Market Cap
  • TATT 384.2M
  • LXRX 428.8M
  • IPO Year
  • TATT 1987
  • LXRX 2000
  • Fundamental
  • Price
  • TATT $39.11
  • LXRX $1.08
  • Analyst Decision
  • TATT Strong Buy
  • LXRX Buy
  • Analyst Count
  • TATT 3
  • LXRX 5
  • Target Price
  • TATT $37.00
  • LXRX $3.23
  • AVG Volume (30 Days)
  • TATT 143.3K
  • LXRX 1.6M
  • Earning Date
  • TATT 08-11-2025
  • LXRX 11-11-2025
  • Dividend Yield
  • TATT N/A
  • LXRX N/A
  • EPS Growth
  • TATT 62.92
  • LXRX N/A
  • EPS
  • TATT 1.19
  • LXRX N/A
  • Revenue
  • TATT $166,749,000.00
  • LXRX $58,432,000.00
  • Revenue This Year
  • TATT $19.87
  • LXRX N/A
  • Revenue Next Year
  • TATT $21.24
  • LXRX N/A
  • P/E Ratio
  • TATT $32.31
  • LXRX N/A
  • Revenue Growth
  • TATT 25.96
  • LXRX 1504.83
  • 52 Week Low
  • TATT $16.25
  • LXRX $0.28
  • 52 Week High
  • TATT $41.00
  • LXRX $2.18
  • Technical
  • Relative Strength Index (RSI)
  • TATT 61.88
  • LXRX 47.19
  • Support Level
  • TATT $35.69
  • LXRX $1.03
  • Resistance Level
  • TATT $37.87
  • LXRX $1.19
  • Average True Range (ATR)
  • TATT 1.74
  • LXRX 0.06
  • MACD
  • TATT 0.23
  • LXRX -0.00
  • Stochastic Oscillator
  • TATT 89.02
  • LXRX 31.94

About TATT TAT Technologies Ltd.

TAT Technologies Ltd provides solutions and services to the commercial and military aerospace and ground defense industries, focused mainly on three product areas and services: Thermal Management, Power and Actuation, and Maintenance, Repair and Overhaul (MRO). Its product portfolio includes heat exchangers, cooling systems, and mechanical aircraft accessories and systems such as pumps, valves, and turbine power units. Its operating segments are MRO services for aviation components, which derive key revenue, Original equipment manufacturing (OEM) of heat transfer solutions and aviation accessories, MRO services for heat transfer components and OEM of heat transfer solutions, and Overhaul and coating of jet engine components. Geographically, it derives key revenue from the United States.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: